Indication

Asymptomatic left ventricular dysfunction

Asymptomatic left ventricular dysfunction is a cardiovascular condition characterized by objective impairment in left ventricular contractile performance or structural remodeling—most commonly defined as a reduced left ventricular ejection fraction of 40% or lower—without overt clinical symptoms of heart failure such as dyspnea, fatigue, or fluid retention. Read more about Asymptomatic left ventricular dysfunction

32 drugs 31 manufacturers

Advertisement

Drugs that treat it

Common Asymptomatic left ventricular dysfunction therapies.

Showing 10–18 of 32 drugs

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
CAMBER PHARMACE

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
SOLCO HEALTHCAR

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
SCIEGEN PHARMAC

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
WILSHIRE PHARMA

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
A-S MEDICATION

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
GSMS, INC.

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
ST MARYS MPP

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
DIRECT RX

ENALAPRIL MALEATE

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS·HYPERTENSION·+2
CHARTWELL RX LL
Filter & compare in the drug finder →Opens the drug finder with Asymptomatic left ventricular dysfunction preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Asymptomatic left ventricular dysfunction.

Asymptomatic left ventricular dysfunction is a cardiovascular condition characterized by objective impairment in left ventricular contractile performance or structural remodeling—most commonly defined as a reduced left ventricular ejection fraction of 40% or lower—without overt clinical symptoms of heart failure such as dyspnea, fatigue, or fluid retention.

Classified clinically as Stage B heart failure, it primarily affects individuals with underlying ischemic heart disease, prior myocardial infarction, long-standing hypertension, or cardiomyopathy.

Pathophysiologically, the condition involves progressive ventricular enlargement, neurohormonal activation, and adverse cardiac remodeling that place patients at significant risk for progression to symptomatic heart failure and premature cardiovascular mortality.

Personalize your experience

Follow Asymptomatic left ventricular dysfunction and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it